Obesity Clinical Trial
Official title:
The Effect of a Stepped-care Approach to Long-term Weight Loss
The number of overweight and obese adults in the United States is increasing at a rapid rate. A "stepped-care" weight loss program, which at key times increases the frequency of contact between an individual trying to lose weight and the program staff, may be beneficial for achieving long-term weight loss. This study will compare a standard behavioral weight loss program with a "stepped-care" weight loss program in their abilities to help people who are overweight or obese to lose weight.
Obesity can lead to many serious health conditions, including high blood pressure, diabetes,
heart disease, and stroke. It is estimated that more than 65% of adults in the United States
are overweight or obese, which is a significant increase over the past two to three decades.
Although numerous studies have identified successful programs that help people achieve
initial weight loss, few weight loss programs have shown promise for long-term success.
Research has shown that a weight loss program in which there is continued contact between
the program leader and the participant may improve long-term weight loss outcomes. In
addition, a stepped-care approach to weight loss, in which contact between the participant
and program leader increases when needed to achieve the next weight loss goal, may be
beneficial. This study will examine whether a long-term weight loss program delivered in a
stepped-care manner results in greater weight loss than does a standard behavioral weight
loss program. Study researchers will also evaluate the cost effectiveness of both programs.
Participants in this 18-month study will be randomly assigned to either a standard
behavioral weight loss program or a stepped-care weight loss program. Participants in the
standard behavioral weight loss program will attend group meetings once a week for Months 1
to 6, every other week for Months 7 to 12, and once a month for Months 13 to 18. The group
meetings will focus on modifying eating habits and physical activity behaviors to improve
weight loss. Participants in the stepped-care weight loss program will take part in a
combination of treatments, whose timing and intensity will depend on the participants'
abilities to achieve predetermined weight loss goals. These treatments may include attending
monthly group meetings, receiving weekly weight loss information in the mail, receiving
telephone calls from study staff to discuss weight loss behaviors, taking part in individual
sessions with study staff to discuss weight loss, and receiving meal replacements (e.g.,
Slim Fast shakes, meal bars). Participants who do not achieve their weight loss goals at
select time points during the study will receive more individual attention from study staff.
All participants will follow a diet that focuses on decreasing calories and fat. They will
be instructed to follow a walking program 5 days a week and to keep a food and exercise
diary. Participants will also have access to a Web site that will include a study calendar
and information about how to change eating and exercise behaviors; the use of this Web site
is optional.
Study visits will occur at baseline and Months 3, 6, 9, 12, 15, and 18. At each visit,
participants' weight and height will be measured, and participants will complete
questionnaires about their mood, general health, and exercise and diet habits. At baseline
and Months 6, 12, and 18, participants will undergo measurements of blood pressure, fat,
muscle, and waist and hip circumferences. Also at these times, physical fitness levels will
be measured through a treadmill walking activity, during which an electrocardiogram (ECG)
will record heart rate. For 7 consecutive days at baseline and Months 6, 12, and 18,
participants will wear an activity monitor to measure physical activity levels.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |